Research news and discoveries from Mass General Brigham
Bench PressBench PressBench PressBench Press
  • Home
  • About Us
  • Science Insights
NextPrevious

Leveraging EHR Notifications to Improve Deprescribing and Medication Safety for Older Adults

January 29, 2026
1

 

Julie C. Lauffenburger, PharmD, PhD

Effectively managing medications for older adults has become a significant challenge in health care, especially when it comes to potentially inappropriate medications (PIMs).

In light of this challenge, a new study explored whether simple nudges in electronic health records (EHRs) could enhance the deprescribing (stopping or tapering) of PIMs in older adults.

The clinical trial, led by Julie Lauffenburger, PharmD, PhD, and Niteesh Choudhry, MD, PhD, from the Division of Pharmacoepidemiology and Pharmacoeconomics at Mass General Brigham, randomized primary care physicians to receive one of two EHR prompts—one designed to promote deprescribing PIMs using behavioral science principles and one with the usual care (no prompts).  

Niteesh Choudhry, MD, PhD

Niteesh Choudhry, MD, PhD

The first intervention, “precommitment,” involved sending an EHR message to physicians during the first patient visit, encouraging them to discuss the potential risks of continuing certain medications.
A follow-up reminder was sent during the second visit to reinforce this discussion. In the second intervention, “boostering,” physicians were sent the same message at the first patient visit, but the follow-up reminder came four weeks later. 

They found that both approaches effectively prompted physicians to initiate deprescribing with eligible patients aged 65 or older. Compared to usual care, deprescribing was 40% more likely in the precommitment group and 26% more likely in the boostering group.

These findings showcase the potential role of behavioral science-based EHR tools in desprescribing high-risk medications on older adults’ medication lists. 

Published in JAMA on January 29, 2026| Read the paper

Summary reviewed by: Julie Lauffenburger, PharmD, PhD, lead author 


 

Category:
Clinical Research
Tags:
Deprescribing

Edita Music

More posts by Edita Music

Related Projects:

Where You Live May Affect Your Chances of Contracting Hidradenitis Suppurativa (HS)

dermatology

View more

Where You Live May Affect Your Chances of Contracting Hidradenitis Suppurativa (HS)

dermatology

Where You Live May Affect Your Chances of Contracting Hidradenitis Suppurativa (HS)
2026-05-12

New Tool Sheds Light on Liver-Disease Specific Stigma

liver conditions substance use disorder

View more

New Tool Sheds Light on Liver-Disease Specific Stigma

liver conditions substance use disorder

New Tool Sheds Light on Liver-Disease Specific Stigma
2026-05-12

New Study Clarifies Swallow Recovery After Robotic Surgery (TORS) for Oropharyngeal Cancer

cancer ear, nose and throat conditions

View more

New Study Clarifies Swallow Recovery After Robotic Surgery (TORS) for Oropharyngeal Cancer

cancer ear, nose and throat conditions

New Study Clarifies Swallow Recovery After Robotic Surgery (TORS) for Oropharyngeal Cancer
2026-05-05

Rising Amputation Rates Among Opioid-Related Hospitalizations

substance use disorder surgery

View more

Rising Amputation Rates Among Opioid-Related Hospitalizations

substance use disorder surgery

Rising Amputation Rates Among Opioid-Related Hospitalizations
2026-05-04

Researchers Develop Genetic Risk Scores for Type 2 Diabetes That Work Well Across Diverse Populations

diabetes genetics

View more

Researchers Develop Genetic Risk Scores for Type 2 Diabetes That Work Well Across Diverse Populations

diabetes genetics

Researchers Develop Genetic Risk Scores for Type 2 Diabetes That Work Well Across Diverse Populations
2026-04-27

No Higher Neurodevelopmental Risks for Children with Prenatal Exposure to Buprenorphine Versus Methadone

substance use disorder

View more

No Higher Neurodevelopmental Risks for Children with Prenatal Exposure to Buprenorphine Versus Methadone

substance use disorder

No Higher Neurodevelopmental Risks for Children with Prenatal Exposure to Buprenorphine Versus Methadone
2026-04-16

Drug Trio Shows Promise in Treating Subset of Metastatic Gastric Cancer Patients

gastric cancer

View more

Drug Trio Shows Promise in Treating Subset of Metastatic Gastric Cancer Patients

gastric cancer

Drug Trio Shows Promise in Treating Subset of Metastatic Gastric Cancer Patients
2026-04-08

Prenatal Exposure to Antiseizure Drugs and Associated Neurodevelopmental Risks

pregnancy and reproductive health

View more

Prenatal Exposure to Antiseizure Drugs and Associated Neurodevelopmental Risks

pregnancy and reproductive health

Prenatal Exposure to Antiseizure Drugs and Associated Neurodevelopmental Risks
2026-04-03

Leave a Comment

Cancel reply

Your email address will not be published. Required fields are marked *

  • Home
  • Research
    • Brain Research
    • Cancer
    • Heart
  • History
    • Nursing History Stories
Bench Press